These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 28682020)

  • 1. Acute Bilateral Anterior Uveitis after a Single Intravenous Infusion of Zoledronic Acid in Metastatic Breast Cancer.
    Jun JH
    Korean J Ophthalmol; 2017 Aug; 31(4):368-369. PubMed ID: 28682020
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
    Moore MM; Beith JM
    Med J Aust; 2008 Mar; 188(6):370-1. PubMed ID: 18341464
    [No Abstract]   [Full Text] [Related]  

  • 3. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A
    J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute anterior uveitis following zoledronic acid infusion for osteoporosis.
    Belliveau MJ; Almeida DR; Urton TE
    Can J Ophthalmol; 2012 Oct; 47(5):e22-3. PubMed ID: 23036555
    [No Abstract]   [Full Text] [Related]  

  • 5. Anterior uveitis complicating zoledronic acid infusion.
    Colucci A; Modorati G; Miserocchi E; Di Matteo F; Rama P
    Ocul Immunol Inflamm; 2009; 17(4):267-8. PubMed ID: 19657981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    El Saghir NS; Otrock ZK; Bleik JH
    BMC Cancer; 2005 Dec; 5():156. PubMed ID: 16332258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diffuse ocular and orbital inflammation after zoledronate infusion-case report and review of the literature.
    Umunakwe OC; Herren D; Kim SJ; Kohanim S
    Digit J Ophthalmol; 2017; 23(4):18-21. PubMed ID: 29403337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial.
    Barrett-Lee P; Casbard A; Abraham J; Hood K; Coleman R; Simmonds P; Timmins H; Wheatley D; Grieve R; Griffiths G; Murray N
    Lancet Oncol; 2014 Jan; 15(1):114-22. PubMed ID: 24332514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute anterior uveitis associated with the use zoledronic acid].
    Cavallasca JA; Reyt C
    Medicina (B Aires); 2014; 74(5):428-9. PubMed ID: 25347912
    [No Abstract]   [Full Text] [Related]  

  • 10. Long interval zoledronic acid use in bone metastases.
    Das M
    Lancet Oncol; 2017 Feb; 18(2):e72. PubMed ID: 28089632
    [No Abstract]   [Full Text] [Related]  

  • 11. The incidence of acute anterior uveitis after intravenous zoledronate.
    Patel DV; Horne A; House M; Reid IR; McGhee CN
    Ophthalmology; 2013 Apr; 120(4):773-6. PubMed ID: 23290982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral Ocular Pain and Hyperemia in a Patient With Paget Disease of the Bone.
    Haider AS; Burbidge AM; Dunlop A
    JAMA Ophthalmol; 2017 Jun; 135(6):665-666. PubMed ID: 28358955
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral ibandronate is as active as intravenous zoledronic acid for reducing bone turnover markers in women with breast cancer and bone metastases.
    Body JJ; Lichinitser M; Tjulandin S; Garnero P; Bergström B
    Ann Oncol; 2007 Jul; 18(7):1165-71. PubMed ID: 17442659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilateral Acute Anterior Uveitis and Conjunctivitis following Intravenous Zoledronic Acid.
    Chatterjee S; Agrawal D
    J Assoc Physicians India; 2017 Jul; 65(7):110-111. PubMed ID: 28792180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.
    Kotteas E; Alamara C; Kiagia M; Pantazopoulos K; Boufas A; Provata A; Charpidou A; Syrigos KN
    Anticancer Res; 2008; 28(1B):529-33. PubMed ID: 18383897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral anterior uveitis complicating zoledronic acid therapy in prostate cancer.
    Banal F; Briot K; Ayoub G; Dougados M; Roux C
    J Rheumatol; 2008 Dec; 35(12):2458-9. PubMed ID: 19040323
    [No Abstract]   [Full Text] [Related]  

  • 17. Renal function changes and NHS resource use in breast cancer patients with metastatic bone disease treated with IV zoledronic acid or oral ibandronic acid: a four-centre non-interventional study.
    Houston S; Grieve RJ; Hickish T; Percival F; Hamilton E
    J Med Econ; 2010 Mar; 13(1):162-7. PubMed ID: 20136578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent hypocalcemia induced by zoledronic acid in a patient with androgen-independent prostate cancer and extensive bone metastases.
    Gulley JL; Wu S; Arlen PM; Dahut WL
    Clin Genitourin Cancer; 2007 Sep; 5(6):403-5. PubMed ID: 17956715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results.
    Morris PG; Poznak CV; Modi S; Mak AF; Patil S; Larson S; Hudis CA; Divgi C; Grewal RK
    Clin Breast Cancer; 2010 Feb; 10(1):33-9. PubMed ID: 20133256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case report: zoledronic acid-induced anterior uveitis.
    Kilickap S; Ozdamar Y; Altundag MK; Dizdar O
    Med Oncol; 2008; 25(2):238-40. PubMed ID: 18488162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.